v3.26.1
Marketable Securities
9 Months Ended
Jun. 30, 2026
Investments, Debt and Equity Securities [Abstract]  
Marketable Securities Marketable Securities
The Company had sales and maturities of marketable securities of $29.0 million and $57.9 million in the three months ended June 30, 2026 and 2025, respectively. The Company had sales and maturities of marketable securities of $295.5 million and $242.5 million in the nine months ended June 30, 2026 and 2025, respectively. There were immaterial realized gains or losses in each of the three and nine months ended June 30, 2026 and 2025 on sales and maturities of marketable securities.
The following is a summary of the amortized cost and the fair value, including accrued interest receivable as well as unrealized gains (losses) on the Company’s short-term and long-term marketable securities as of June 30, 2026 and September 30, 2025 (in thousands):
Amortized
Cost
Gross
Unrealized
Losses
Gross
Unrealized
Gains
Fair Value
June 30, 2026:
U.S. Treasury securities and obligations of U.S. government agencies$244,688 $(853)$$243,837 
Bank certificates of deposit1,253 (1)— 1,252 
Corporate securities72,907 (468)— 72,439 
Municipal securities14,722 (28)14,702 
$333,570 $(1,350)$10 $332,230 
September 30, 2025:
U.S. Treasury securities and obligations of U.S. government agencies$245,691 $(94)$168 $245,765 
Bank certificates of deposit1,640 — 1,641 
Corporate securities4,199 — — 4,199 
Municipal securities11,048 — 69 11,117 
$262,578 $(94)$238 $262,722 
The amortized cost and fair value of the marketable securities by contractual maturities as of June 30, 2026 are presented below (in thousands):
Amortized
Cost
Fair Value
Due in one year or less$136,293 $136,143 
Due after one year through five years192,988 191,798 
Due after ten years4,289 4,289 
Total marketable securities$333,570 $332,230 
Expected maturities could differ from contractual maturities because the security issuers may have the right to prepay obligations without prepayment penalties.
Unrealized gains and losses from fixed-income securities are primarily attributable to changes in interest rates. The Company does not believe any unrealized losses represent impairments based on the evaluation of the available evidence.